Amanda Pacheco de Alencar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amanda Pacheco de Alencar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Adriano de Paula Sabino
Federal Institute of Minas Gerais
1 shared publication- Adriano de Paula Sabino
Federal University of Minas Gerais—UFMG
1 shared publication - Amanda F. M. de Oliveira
Social Pharmacy Department, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil
1 shared publication - Ana L. G. F. Figueiredo
Clinical Analysis and Toxicological Analysis, Pharmacy Faculty, Federal University of Minas Gerais, Belo Horizonte 31270-901, Brazil
1 shared publication Ana Luiza Gonzaga Ferreira Figueiredo
Federal Institute of Minas Gerais
1 shared publication- Cristina M. Ruas
Social Pharmacy Department, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1615
Long COVID and Its Impacts: A Case–Control Study in Brazil
Introduction: Long COVID, or post-COVID-19 syndrome, refers to a set of persistent symptoms following SARS-CoV-2 infection without another identifiable cause. Studies indicate that symptoms can last for up to two years and affect multiple body systems. Objective: The objective of this study is to compare symptom prevalence between infected individuals pre and post-COVID-19 and non-infected individuals in a population from Southeastern Brazil. Materials and Methods: A case–control study was conducted with participants from the MonitoraCovid program in a university in Brazil. The study included adults who responded to a questionnaire about long COVID symptoms. Data were collected virtually between October 2023 and May 2024. Results: Of the 2886 individuals eligible for analysis, 75.5% reported having been positive for COVID-19. Most participants were vaccinated, with 82.99% receiving two doses. In the pre and post comparison, individuals who had COVID-19 were more likely to report increased symptoms after infection, with 95.5% of assessed conditions worsening, particularly cognitive and respiratory issues. A comparison between those who had and had not been infected with COVID-19 showed that only 6.67% of symptoms were more prevalent in the infected group. The most significant post-COVID-19 symptoms included memory problems, fatigue, and shortness of breath, though some conditions, such as anxiety and sleep disturbances, were less common among those who had COVID-19. Conclusions: The findings reinforce that long COVID significantly impacts cognitive health, highlighting the importance of monitoring previously infected individuals. The study also emphasizes the need for further research in Global South contexts to better understand the long-term implications of COVID-19.
- 1 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (7) , 1615
Open AccessLong COVID and Its Impacts: A Case–Control Study in Brazil
Introduction: Long COVID, or post-COVID-19 syndrome, refers to a set of persistent symptoms following SARS-CoV-2 infection without another identifiable cause. Studies indicate that symptoms can last for up to two years and affect multiple body systems. Objective: The objective of this study is to compare symptom prevalence between infected individuals pre and post-COVID-19 and non-infected individuals in a population from Southeastern Brazil. Materials and Methods: A case–control study was conducted with participants from the MonitoraCovid program in a university in Brazil. The study included adults who responded to a questionnaire about long COVID symptoms. Data were collected virtually between October 2023 and May 2024. Results: Of the 2886 individuals eligible for analysis, 75.5% reported having been positive for COVID-19. Most participants were vaccinated, with 82.99% receiving two doses. In the pre and post comparison, individuals who had COVID-19 were more likely to report increased symptoms after infection, with 95.5% of assessed conditions worsening, particularly cognitive and respiratory issues. A comparison between those who had and had not been infected with COVID-19 showed that only 6.67% of symptoms were more prevalent in the infected group. The most significant post-COVID-19 symptoms included memory problems, fatigue, and shortness of breath, though some conditions, such as anxiety and sleep disturbances, were less common among those who had COVID-19. Conclusions: The findings reinforce that long COVID significantly impacts cognitive health, highlighting the importance of monitoring previously infected individuals. The study also emphasizes the need for further research in Global South contexts to better understand the long-term implications of COVID-19.
- Open Access
- 27 May 2024
- Published by Qeios Ltd in Qeios Preprints
Long COVID Syndrome: A Systematic Review of Persistent Symptoms Post-Pandemic
The manifestation of persistent symptoms following COVID-19 infection, also known as Long COVID, is recognized by the World Health Organization. However, uncertainties remain regarding the symptoms, definitions of this condition, and its manifestation in the population. Therefore, this systematic review aims to provide an overview of the centrally published reviews describing persistent symptoms and critically analyze existing studies to identify gaps and propose new research perspectives. Initially, relevant studies were researched, followed by selection based on the titles and abstracts of articles obtained from the PubMed electronic database up to May 2023. Subsequently, the selected studies underwent a thorough analysis and interpretation of results, and pre-defined inclusion and exclusion criteria were considered. The inclusion criteria considered only English articles that conducted systematic reviews and meta-analyses of primary studies on persistent symptoms following SARS-CoV-2 infection. To maintain the generalizability of the results, studies that restricted the age of participants or considered samples with specific clinical conditions (comorbidities) were excluded. A total of 10 articles published between 2021 and 2022 were identified, encompassing a sample ranging from 4,664 to 257,348 adult patients, predominantly from the northern hemisphere. The studies focus on identifying the prevalence of symptoms following acute infection in individuals who tested positive for COVID-19, regardless of hospitalization status. Only one article offered a comparative perspective between positive and negative groups. The post-acute phase range varied from short periods (14 days) to long-term (over one year). The prevalence of symptoms varied over time. The most prevalent symptoms of Long COVID, regardless of the post-acute phase time range, were fatigue and dyspnea. A knowledge gap was identified in this research field, necessitating further investigation and the search for solid evidence to understand the persistent symptoms associated with COVID-19.
- 27 May 2024
- Published by Qeios Ltd in Qeios Preprints
Open AccessLong COVID Syndrome: A Systematic Review of Persistent Symptoms Post-Pandemic
The manifestation of persistent symptoms following COVID-19 infection, also known as Long COVID, is recognized by the World Health Organization. However, uncertainties remain regarding the symptoms, definitions of this condition, and its manifestation in the population. Therefore, this systematic review aims to provide an overview of the centrally published reviews describing persistent symptoms and critically analyze existing studies to identify gaps and propose new research perspectives. Initially, relevant studies were researched, followed by selection based on the titles and abstracts of articles obtained from the PubMed electronic database up to May 2023. Subsequently, the selected studies underwent a thorough analysis and interpretation of results, and pre-defined inclusion and exclusion criteria were considered. The inclusion criteria considered only English articles that conducted systematic reviews and meta-analyses of primary studies on persistent symptoms following SARS-CoV-2 infection. To maintain the generalizability of the results, studies that restricted the age of participants or considered samples with specific clinical conditions (comorbidities) were excluded. A total of 10 articles published between 2021 and 2022 were identified, encompassing a sample ranging from 4,664 to 257,348 adult patients, predominantly from the northern hemisphere. The studies focus on identifying the prevalence of symptoms following acute infection in individuals who tested positive for COVID-19, regardless of hospitalization status. Only one article offered a comparative perspective between positive and negative groups. The post-acute phase range varied from short periods (14 days) to long-term (over one year). The prevalence of symptoms varied over time. The most prevalent symptoms of Long COVID, regardless of the post-acute phase time range, were fatigue and dyspnea. A knowledge gap was identified in this research field, necessitating further investigation and the search for solid evidence to understand the persistent symptoms associated with COVID-19.